The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia

被引：1
|
作者：
Washio, Yasuyoshi
Ito, Akihiro
Kumagai, Shogo
Ishida, Tadashi
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Infections; Sepsis;
D O I：
10.1183/13993003.congress-2016.PA605
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA605
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The impact of pneumococcal bacteremia on the management of community acquired pneumonia
    Waterer, GW
    Jennings, SG
    Wunderink, RG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A846 - A846
  • [2] RISK FACTORS FOR MORTALITY IN COMMUNITY-ACQUIRED BACTEREMIC PNEUMOCOCCAL PNEUMONIA
    Boronat, P.
    Cano, S.
    Anglada, M.
    Fernando, A.
    Almirall, J.
    Mesalles, E.
    Gimenez, M.
    Sauca, G.
    Modol, J. M.
    Moreno, J. M.
    Klamburg, J.
    INTENSIVE CARE MEDICINE, 2009, 35 : 89 - 89
  • [3] Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
    Fernandez, Leyre Serrano
    Zalacain, Rafael
    Capelastegi, Alberto
    Gomez, Ainhoa
    Martinez-Indart, Lorea
    Garcia, Marta
    Uranga, Ane
    Espana, Pedro Pablo
    Ruiz, Luis Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [4] Pneumococcal virulence factors in community-acquired pneumonia
    Feldman, Charles
    Anderson, Ronald
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 222 - 231
  • [5] Exploring the risk factors for community- acquired Clostridium difficile
    Bell, Allison
    Pippin, Ethan
    PHARMACOTHERAPY, 2016, 36 (12): : E207 - E207
  • [6] Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia
    Kang, Cheol-In
    Song, Jae-Hoon
    Kim, So Hyun
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Thamlikitkul, Visanu
    Wang, Hui
    So, Thomas Man-kit
    Hsueh, Po-Ren
    Yasin, Rohani Md.
    Carlos, Celia C.
    Pham Hung Van
    Perera, Jennifer
    JOURNAL OF INFECTION, 2013, 66 (01) : 34 - 40
  • [7] Cumulative clinical trial experience with levofloxacin for patients with community-acquired pneumonia-associated pneumococcal bacteremia
    Kahn, JB
    Bahal, N
    Wiesinger, BA
    Xiang, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 : S34 - S42
  • [8] Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome
    Ruiz Iturriaga, Luis Alberto
    Serrano Fernandez, Leyre
    Gonzalez Quero, Beatriz
    Gomez Bonilla, Ainhoa
    Perez Fernandez, Silvia
    Rezola Carasusan, Alejandro
    Artaraz Ereno, Amaia
    Solorzano Santobena, Jone
    Gonzalez Munoz, Imanol
    Espana Yandiola, Pedro Pablo
    Zalacain Jorge, Rafael
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] CAN WE PREDICT PNEUMOCOCCAL BACTEREMIA IN PATIENTS WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA?
    Pereira, J. M.
    Teixeira-Pinto, A.
    Basilio, C.
    Sousa-Dias, C.
    Mergulhao, P.
    Paiva, J. A.
    INTENSIVE CARE MEDICINE, 2012, 38 : S129 - S129
  • [10] Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
    Uranga, Ane
    Capelastegui, Alberto
    Pablo Espana, Pedro
    Diez, Rosa
    Zalacain, Rafael
    Alberto Lopez, Luis
    Bilbao, Amaia
    Patricia Martinez, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345